CHEMED CORP

For the period ended Dec 31, 2025. Filed Feb 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 27, 2026

CHE$544.49+1.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Consolidating Statements of Income

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
UNAUDITED CONSOLIDATING STATEMENTS OF INCOME
FOR THE YEAR ENDED DECEMBER 31, 2025
(in thousands)(unaudited)
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
Service revenues and sales		$1,630,101		$899,877	$	-	$2,529,978
Cost of services provided and goods sold		1,257,704		449,090		-	1,706,794
Selling, general and administrative expenses		100,675		247,047		69,466	417,188
Depreciation		21,308		33,200		49	54,557
Amortization		104		10,180		-	10,284
Other operating expense/(income)		3,375		(466)		-	2,909
Total costs and expenses		1,383,166		739,051		69,515	2,191,732
Income/(loss) from operations		246,935		160,826		(69,515)	338,246
Interest expense		(185)		(611)		(954)	(1,750)
Intercompany interest income/(expense)		22,455		16,245		(38,700)	-
Other income—net		327		70		18,885	19,282
Income/(loss) before income taxes (a)		269,532		176,530		(90,284)	355,778
Income taxes		(65,523)		(41,037)		16,020	(90,540)
Net income/(loss) (a)		$204,009		$135,493		$(74,264)	$265,238
(a) The following amounts are included in income from continuing operations (in thousands):
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
Pretax benefit/(cost):
Stock option expense	$	-	$	-		$(32,671)	$(32,671)
Amortization of reacquired franchise agreements		-		(9,408)		-	(9,408)
Long-term incentive compensation		-		-		(5,625)	(5,625)
Legal settlements		(3,071)		-		-	(3,071)
Other		(500)		(530)		(2,690)	(3,720)
Total		$(3,571)		$(9,938)		$(40,986)	$(54,495)
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
After-tax benefit/(cost):
Stock option expense	$	-	$	-		$(27,659)	$(27,659)
Amortization of reacquired franchise agreements		-		(7,216)		-	(7,216)
Long-term incentive compensation		-		-		(4,972)	(4,972)
Legal settlements		(2,325)		-		-	(2,325)
Other		(378)		(406)		(2,690)	(3,474)
Excess tax expense on stock compensation		-		-		(696)	(696)
Total		$(2,703)		$(7,622)		$(36,017)	$(46,342)

‎

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
UNAUDITED CONSOLIDATING STATEMENTS OF INCOME
FOR THE YEAR ENDED DECEMBER 31, 2024
(in thousands)(unaudited)
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
Service revenues and sales		$1,530,978		$900,309	$	-	$2,431,287
Cost of services provided and goods sold		1,146,803		430,136		-	1,576,939
Selling, general and administrative expenses		99,564		232,852		91,944	424,360
Depreciation		20,362		32,452		50	52,864
Amortization		105		10,080		-	10,185
Other operating expenses		178		268		-	446
Total costs and expenses		1,267,012		705,788		91,994	2,064,794
Income/(loss) from operations		263,966		194,521		(91,994)	366,493
Interest expense		(171)		(431)		(1,178)	(1,780)
Intercompany interest income/(expense)		20,211		14,397		(34,608)	-
Other income—net		227		69		34,456	34,752
Income/(loss) before income taxes (a)		284,233		208,556		(93,324)	399,465
Income taxes		(67,414)		(48,510)		18,458	(97,466)
Net income/(loss) (a)		$216,819		$160,046		$(74,866)	$301,999
(a) The following amounts are included in income from continuing operations (in thousands):
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
Pretax benefit/(cost):
Stock option expense	$	-	$	-		$(32,033)	$(32,033)
Long-term incentive compensation		-		-		(20,152)	(20,152)
Amortization of reacquired franchise agreements		-		(9,408)		-	(9,408)
Acquisition expense		(1,099)		(34)		-	(1,133)
Total		$(1,099)		$(9,442)		$(52,185)	$(62,726)
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
After-tax benefit/(cost):
Stock option expense	$	-	$	-		$(27,053)	$(27,053)
Long-term incentive compensation		-		-		(18,504)	(18,504)
Amortization of reacquired franchise agreements		-		(7,216)		-	(7,216)
Acquisition expense		(832)		(26)		-	(858)
Excess tax benefits on stock compensation		-		-		4,442	4,442
Total		$(832)		$(7,242)		$(41,115)	$(49,189)

‎

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
UNAUDITED CONSOLIDATING STATEMENTS OF INCOME
FOR THE YEAR ENDED DECEMBER 31, 2023
(in thousands)(unaudited)
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
Service revenues and sales		$1,315,065		$949,352	$	-	$2,264,417
Cost of services provided and goods sold		1,017,623		447,979		-	1,465,602
Selling, general and administrative expenses		93,296		231,587		70,237	395,120
Depreciation		19,959		30,790		53	50,802
Amortization		104		9,959		-	10,063
Other operating expenses/(income)		(12)		2,273		-	2,261
Total costs and expenses		1,130,970		722,588		70,290	1,923,848
Income/(loss) from operations		184,095		226,764		(70,290)	340,569
Interest expense		(180)		(442)		(2,486)	(3,108)
Intercompany interest income/(expense)		19,400		11,918		(31,318)	-
Other income—net		1,309		126		11,471	12,906
Income/(loss) before income taxes (a)		204,624		238,366		(92,623)	350,367
Income taxes		(46,115)		(50,125)		18,382	(77,858)
Net income/(loss) (a)		$158,509		$188,241		$(74,241)	$272,509
(a) The following amounts are included in income from continuing operations (in thousands):
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
Pretax benefit/(cost):
Stock option expense	$	-	$	-		$(30,082)	$(30,082)
Long-term incentive compensation		-		-		(11,689)	(11,689)
Amortization of reacquired franchise agreements		-		(9,408)		-	(9,408)
Legal settlements		-		(2,056)		-	(2,056)
Total	$	-		$(11,464)		$(41,771)	$(53,235)
Roto- · Chemed
VITAS · Rooter · Corporate · Consolidated
After-tax benefit/(cost):
Stock option expense	$	-	$	-		$(25,405)	$(25,405)
Long-term incentive compensation		-		-		(10,379)	(10,379)
Amortization of reacquired franchise agreements		-		(7,216)		-	(7,216)
Impact of deferred rate tax change		1,772		3,559		(1,090)	4,241
Legal settlements		-		(1,577)		-	(1,577)
Excess tax benefits on stock compensation		-		-		4,330	4,330
Total		$1,772		$(5,234)		$(32,544)	$(36,006)

‎

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.